Chart Industries, Inc.

Fundamentals4.0
Price Action5.0
News Sentiment0.0
AI Rating
5.0

Key Drivers

  • Cash generation
  • Margin pressure
  • Debt burden

AI
AI Summary

5.0

GTLS now looks more like a deal-driven trade than a clean industrial compounder: Baker Hughes' EU remedies keep the takeover alive and support the downside floor, but weak margins, negative free cash flow, and heavy leverage mean near-term upside depends more on regulatory approval than operating improvement.

M&A‍
Leverage
RegulatoryRisk

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

4.0

Key Financial Insights:

  • Cash generation
  • Margin pressure
  • Debt burden

GTLS has a credible cash-generating base, but weakening margins, heavy leverage, and thin interest coverage make the stock a higher-risk, only selectively attractive investment.

cashflow
leverage

Price Behavior

5.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Range Holding
  • Capped Upside
  • Low Volatility

GTLS has spent the last month in a tight consolidation, holding support around $206.50–$207.00 but repeatedly stalling near $208.80–$209.00, so the setup is neutral with a slight constructive bias but no breakout confirmation.

neutral
consolidation
Support Level: $206.50–$207.00
Resistance Level: $208.80–$209.00

Tight range near the highs with no decisive breakout

Sentiment & News

0.0

Key News Insights:

  • EU remedies
  • Approval milestone
  • Deal progress

Baker Hughes moved closer to closing its $13.6 billion Chart Industries acquisition by offering EU remedies to address antitrust concerns, signaling regulatory approval remains the key hurdle.

ApprovalProgress
Antitrust

The filing is a modestly positive step for GTLS, as it lowers regulatory risk and keeps the takeover on track